Evidence Brief: Cost Savings

Lit review
par
Hyshka, Elaine et al

Date de publication

2021

Géographie

Canada

Langue de la ressource

English, French and Spanish

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

No

L’objectif

This evidence brief seeks to answer the question: are supervised consumption services (SCS) cost-effective measures?

Constatations/points à retenir

All of the studies that were identified found that SCS save money. However, there is less agreement across the studies on exactly how much money is saved, and whether these savings can be directly attributed to SCS activities (as opposed to similar activities provided through other complementary services; e.g., needle distribution programs). Estimated savings resulting from Insite range from $200,000 to $6 million annually, depending on the modelling approach and variables included. Therefore, while there is a lack of agreement regarding the extent of the savings, the consensus is that Insite saves money overall.

La conception ou méthodologie de recherche

This is a review of existing research on cost benefit analysis of SCS. It is unclear how many articles were included in their review, however a summarizing table of five articles are presented.

Mots clés

Advocacy
Harm reduction
SCS/OPS